Mouthpiece may offer new hope for severe sleep apnea sufferers
NCT ID NCT07090395
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a custom mouthpiece called EVO can safely treat severe obstructive sleep apnea. About 49 adults with severe sleep apnea will use the device, which moves the jaw forward to keep the airway open. The goal is to see if it reduces breathing pauses by at least half and keeps them below a safe level after 6 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mount Sinai Integrative Sleep Center
RECRUITINGNew York, New York, 10010, United States
-
Star Sleep and Wellness
RECRUITINGDallas, Texas, 75251, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do current sleepiness tests work for kids? a new study puts them to the test
- Remote monitoring may boost sleep apnea therapy adherence
- Could a mouthpiece replace the CPAP machine for sleep apnea?
- Can a new painkiller prevent breathing crises after surgery?
- Personalizing sleep apnea treatment: a step toward better CPAP outcomes
- A blood test for sleep apnea? MicroRNAs may hold the key